Innovative Oncology, A Conversation with iOnctura

In Vivo spoke with UK biotech CEO Catherine Pickering about developing innovative therapies for challenging cancer types, the progress of iOntura's lead asset, roginolisib, for uveal melanoma, and the strategies that have helped secure over €100m in private financing.

Episode metadata supplied by the publisher feed · Published Mar 28, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Innovative Oncology, A Conversation with iOnctura

0:00 35:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 35 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on March 28, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!